Mga Batayang Estadistika
| LEI | 300300DMUYLW3FP1OT73 |
| CIK | 1615258 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 7, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* Check-Cap Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.20 per share (Title of Class of Securities) M2361E 112 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| August 31, 2017 |
Exhibit 99.1 JOINT FILING AGREEMENT Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the rules and regulations thereunder, each party hereto hereby agrees to the joint filing, on behalf of each of them, of any filing required by such party under Section 13 or Section 16 of the Exchange Act or any rule or regulation thereunder (including a |
|
| August 31, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Impax Laboratories, Inc. (Name of Issuer) Common Stock, par value US$0.01 per share (Title of Class of Securities) 45256B101 (CUSIP Number) August 21, 2017 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| January 20, 2017 |
Check-Cap SC 13G/A (Passive Acquisition of More Than 5% of Shares) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* Check-Cap Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.20 per share (Title of Class of Securities) M2361E 112 (CUSIP Number) December 31, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| January 28, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* Check-Cap Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.20 per share (Title of Class of Securities) M2361E 112 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| May 15, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Check-Cap Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.20 per share (Title of Class of Securities) M2361E 112 (CUSIP Number) February 24, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the ru |
|
| March 17, 2015 |
CHEK / Check-Cap Ltd. / Shanghai Fosun Pharmaceutical (Group) Co., Ltd. - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Check-Cap Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.20 per share (Title of Class of Securities) M2361E 112 (CUSIP Number) February 24, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rul |
|
| September 2, 2014 |
SC 13D/A 1 formsc13da.htm SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO., LTD SC 13DA 8-25-2014 (NATURE?S SUNSHINE PRODUCTS, INC.) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A (Amendment No. 1) Under the Securities Exchange Act of 1934 Nature’s Sunshine Products, Inc. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 639027101 (CUSIP Nu |
|
| August 4, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Nature’s Sunshine Products, Inc. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 639027101 (CUSIP Number) Dongjiu Li Shanghai Fosun Pharmaceutical (Group) Co., Ltd. No. 2 East Fuxing Road Shanghai 200010, P.R. China Telephone: +86 (21) 63325501 F |
|
| August 4, 2014 |
EXHIBIT 99.1 DIRECTORS AND EXECUTIVE OFFICERS OF FOSUN PHARMA, PERSONS CONTROLLING FOSUN PHARMA AND EXECUTIVE OFFICERS AND DIRECTORS OF OTHER PERSONS IN CONTROL OF FOSUN PHARMA Fosun Pharma is a corporation organized under the laws of the People’s Republic of China and listed on both the Shanghai Stock Exchange and The Stock Exchange of Hong Kong Limited with its principal business address at No. |
